NUTX Financial Statements & Analysis
Complete financial statements for NUTX including income statement, balance sheet, and cash flow statement. Analyze NUTX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
82.4% ↑
Net Income
35.7% ↑
Gross Margin
24.1% ↑
Operating Margin
15.7% ↑
Balance Sheet
Current Ratio
64.3% ↑
Debt to Equity
-54.1% ↑
Asset Turnover
30.1% ↑
Cash Flow
Operating Cash Flow
971.6% ↑
Net Cash Flow
573.0% ↑
Free Cash Flow
1077.9% ↑
Cash Flow to Debt
937.8% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 479.95M | 875.26M | 82.4% | |
| Gross Profit | 196.26M | 444.28M | 126.4% | |
| Operating Income | 130.62M | 275.63M | 111.0% | |
| Net Income | 52.18M | 70.79M | 35.7% | |
| EPS | 10.23 | 11.13 | 8.8% | |
| EBITDA | 148.65M | 287.54M | 93.4% | |
| Gross Margin | 40.89% | 50.76% | 24.1% | |
| Operating Margin | 27.22% | 31.49% | 15.7% | |
| Net Income Margin | 10.87% | 8.09% | 25.6% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 875.26M | 479.95M | 247.65M | — | — |
| Gross Profit | 444.28M | 196.26M | 34.77M | — | — |
| Operating Income | 275.63M | 130.62M | -31.77M | — | — |
| Net Income | 70.79M | 52.18M | -45.79M | — | — |
| EPS | 11.13 | 10.23 | -10.39 | — | — |
| EBITDA | 287.54M | 148.65M | -14.58M | — | — |
| Gross Margin | 50.76% | 40.89% | 14.04% | — | — |
| Operating Margin | 31.49% | 27.22% | -12.83% | — | — |
| Net Income Margin | 8.09% | 10.87% | -18.49% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into NUTX's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics